A blow to cancer research in the UK as National Cancer Institute closes down
The National Cancer Research Institute (NCRI) in the UK announced that it is shutting down after 22 years, citing economic uncertainty.
Oximio WP
ASCO 2023: Janssen present positive follow-up data for first in line therapy for lung cancer
Elicio reports positive interim clinical data of cancer immunotherapy study
AstraZeneca reports positive results from endometrial cancer therapy trial
Rate of breast density loss may indicate risk of breast cancer
AstraZeneca reports positive data from lung cancer combo therapy trial
Anixa’s breast cancer vaccine shows promise in Phase I trial
Pipeline Moves: late-stage oncology trial terminations, approval prospects plunge
